We are live on ! Find out more
JHMH

John Hancock Multifactor Healthcare ETF

Delisted

JHMH was delisted on the 24th of October, 2022.

22 hedge funds and large institutions have $21.5M invested in John Hancock Multifactor Healthcare ETF in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 2422 (-2)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

24% less capital invested

Capital invested by funds: $28.2M → $21.5M (-$6.7M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
6
Reduced
7
Closed
4
Calls
Puts
Net Calls
Net Calls Change

JHMH Hedge Fund Activity: Q3 2022 in Review

22 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in John Hancock Multifactor Healthcare ETF (JHMH) for Q3 2022, worth a combined $21.5M — down 24% from $28.2M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of JHMH and 2 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Royal Bank of Canada, adding an estimated $2.32M. The largest seller was Brinker Capital Investments, exiting entirely with an estimated $3.19M sold.

  • 22 institutional investors held John Hancock Multifactor Healthcare ETF (JHMH) as of Q3 2022, down from 24 in Q2 2022.
  • Funds reported $21.5M of John Hancock Multifactor Healthcare ETF stock for Q3 2022, down 24% quarter-over-quarter.
  • 2 funds opened new John Hancock Multifactor Healthcare ETF positions in Q3 2022 and 4 closed out, a net change of -2 holders.
  • The largest John Hancock Multifactor Healthcare ETF buyer in Q3 2022 was Royal Bank of Canada, an estimated $2.32M added.
  • The largest John Hancock Multifactor Healthcare ETF seller in Q3 2022 was Brinker Capital Investments, an estimated $3.19M sold.

Based on aggregated 13F filings for Q3 2022.